WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
DHAI
DIH HOLDING US INC
NASDAQ
Medical Devices
$64.87M$1.60-1.23%$1.21MN/A-1.97
DRMA
DERMATA THERAPEUTICS INC
NASDAQ
Biotechnology
$1.67M$3.76-10.48%-$8.69M-0.14x0.36
RNXT
RENOVORX INC
NASDAQ
Biotechnology
$33.53M$1.402.19%-$7.94M-1.94x1.71
ELTX
ELICIO THERAPEUTICS INC
NASDAQ
Biotechnology
$101.27M$9.86-1.89%-$36.83M-1.14x4.03
EHAB
ENHABIT INC
NYSE
Medical Care Facilities
$448.89M$8.958.48%-$19.50M-5.39x1.10
ELAN
ELANCO ANIMAL HEALTH INC
NYSE
Drug Manufacturers - Specialty & Generic
$8.40B$17.00-1.11%-$325.00M-6.42x1.32
GRTX
GALERA THERAPEUTICS INC
NASDAQ
Biotechnology
$10.12M$0.19-5.10%-$38.31M-0.20x-1.15
BTSG
BRIGHTSPRING HEALTH SERVICES INC
NASDAQ
Health Information Services
$1.96B$11.45-0.17%N/AN/A2.60
SOLV
SOLVENTUM CORP
NYSE
Health Information Services
$10.71B$62.03-0.56%N/AN/A2.82
ISPC
ISPECIMEN INC
NASDAQ
Diagnostics & Research
$2.47M$0.252.90%-$9.41M-0.19x0.84
MTEM
MOLECULAR TEMPLATES INC
NASDAQ
Biotechnology
$9.41M$1.43-1.38%-$11.28M-1.29x3.62
BIOL
BIOLASE INC
NASDAQ
Medical Devices
$5.38M$0.161.26%-$15.50M-0.01x-17.62
VERO
VENUS CONCEPT INC
NASDAQ
Medical Devices
$4.00M$0.631.45%-$26.52M-0.09x-4.64
MNDR
MOBILE-HEALTH NETWORK SOLUTIONS
NASDAQ
Health Information Services
$65.62M$1.93-4.46%N/AN/A70.64
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$6.99M$0.423.74%-$4.96M-0.90x0.72
OPGN
OPGEN INC
NASDAQ
Medical Devices
$3.87M$3.86-16.09%-$22.42M-0.06x5.78
CTNM
CONTINEUM THERAPEUTICS INC
NASDAQ
Biotechnology
$404.11M$15.711.35%N/AN/A-0.09
MYMD
MYMD PHARMACEUTICALS INC
NASDAQ
Biotechnology
$5.49M$2.381.28%-$12.29M-0.25x0.43
AXDX
ACCELERATE DIAGNOSTICS INC
NASDAQ
Medical Devices
$19.34M$0.88-0.57%-$46.13M-0.20x-2.19
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$19.04B$16.813.19%$1.64B-38.20x4.84
KA
KINETA INC
NASDAQ
Biotechnology
$5.89M$0.486.42%-$16.76M-0.32x-1.36
CADL
CANDEL THERAPEUTICS INC
NASDAQ
Biotechnology
$356.34M$11.984.17%-$33.50M-9.36x4.22
RENB
RENOVARO INC
NASDAQ
Biotechnology
$143.08M$0.970.00%-$52.90M-1.24x0.26
RANI
RANI THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$264.71M$5.250.57%-$25.87M-4.07x5.27
AONC
AMERICAN ONCOLOGY NETWORK INC
NASDAQ
Medical Care Facilities
$96.71M$2.63-12.62%N/AN/A-2.19
CPHI
CHINA PHARMA HOLDINGS INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$5.67M$0.368.84%-$454.86k-0.53x0.95
ANVS
ANNOVIS BIO INC
NYSE
Biotechnology
$97.75M$8.755.29%-$47.53M-1.71x-3.33
ENGN
ENGENE HOLDINGS INC
NASDAQ
Biotechnology
$552.18M$12.67-2.39%N/AN/A0.50
EFTR
EFFECTOR THERAPEUTICS INC
NASDAQ
Biotechnology
$8.80M$1.87-3.61%-$31.54M-0.15x31.81
ZVSA
ZYVERSA THERAPEUTICS INC
NASDAQ
Biotechnology
$3.51M$4.20-6.40%-$105.98M-0.00x0.93
NUWE
NUWELLIS INC
NASDAQ
Medical Devices
$4.64M$0.26-0.77%-$14.21M-0.03x6.53
PMN
PROMIS NEUROSCIENCES INC
NASDAQ
Biotechnology
$34.98M$1.850.00%-$11.59M-2.49x45.02
VRPX
VIRPAX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$905.36k$0.77-1.02%-$16.89M-0.05x-3.58
LIFW
MSP RECOVERY INC
NASDAQ
Health Information Services
$98.88M$0.71-7.96%$274.74M-0.11x6.83
TTOO
T2 BIOSYSTEMS INC
NASDAQ
Diagnostics & Research
$53.29M$6.067.45%-$38.59M-0.53x-1.66
BPTH
BIO-PATH HOLDINGS INC
NASDAQ
Biotechnology
$3.59M$2.171.40%-$13.78M-0.08x-1.67
COCH
ENVOY MEDICAL INC
NASDAQ
Medical Devices
$63.50M$3.244.18%-$22.83M-15.43x-2.14
NRSN
NEUROSENSE THERAPEUTICS LTD
NASDAQ
Biotechnology
$19.38M$1.264.13%-$8.97M-1.52x-2.70
QLGN
QUALIGEN THERAPEUTICS INC
NASDAQ
Biotechnology
$1.86M$0.300.68%-$11.89M-0.11x-1.97
ALZN
ALZAMEND NEURO INC
NASDAQ
Biotechnology
$4.35M$0.63-0.16%-$12.35M-0.34x-1.07
CNSP
CNS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.56M$0.22-0.46%-$17.45M-0.06x-1.38
CNTG
CENTOGENE NV
NASDAQ
Diagnostics & Research
$10.51M$0.382.97%-$20.95M-0.28x-4.05
HCWB
HCW BIOLOGICS INC
NASDAQ
Biotechnology
$41.98M$1.110.91%-$26.12M-1.46x2.48
MOVE
MOVANO INC
NASDAQ
Medical Devices
$42.65M$0.432.36%-$27.45M-0.79x-4.47
WINT
WINDTREE THERAPEUTICS INC
NASDAQ
Biotechnology
$2.59M$4.37-2.67%-$5.32M-0.12x0.95
AMRX
AMNEAL PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.08B$6.73-1.32%$299.04M-9.09x-55.24
NRXP
NRX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$43.44M$4.0614.69%-$25.28M-1.29x-1.25
IVA
INVENTIVA SA
NASDAQ
Biotechnology
$193.14M$3.71-2.32%-$109.06M-1.40x-3.17
AGEN
AGENUS INC
NASDAQ
Biotechnology
$224.69M$10.70-1.47%-$114.19M-0.85x-2.22
ARMP
ARMATA PHARMACEUTICALS INC
NYSEMKT
Biotechnology
$89.66M$2.48-4.25%-$74.07M-1.13x-3.13
AKTX
AKARI THERAPEUTICS PLC
NASDAQ
Biotechnology
$24.09M$1.520.00%N/AN/A-1.78
CUTR
CUTERA INC
NASDAQ
Medical Devices
$45.36M$2.261.80%-$135.39M-0.29x-2.62
CERO
CERO THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$15.97M$1.06-3.64%N/AN/A-3.28
XFOR
X4 PHARMACEUTICALS INC
NASDAQ
Biotechnology
$151.14M$0.90-3.02%-$120.35M-1.30x107.28
ALLR
ALLARITY THERAPEUTICS INC
NASDAQ
Biotechnology
$11.04M$0.63-1.88%-$11.78M-0.00x-2.85
OKYO
OKYO PHARMA LTD
NASDAQ
Biotechnology
$38.07M$1.49-1.97%-$13.18M-2.44x-3.53
BCTX
BRIACELL THERAPEUTICS CORP
NASDAQ
Biotechnology
$23.81M$1.497.19%-$17.21M-1.86x-2.55
VINC
VINCERX PHARMA INC
NASDAQ
Biotechnology
$20.14M$0.68-1.30%-$37.22M-0.38x-18.82
LSDI
LUCY SCIENTIFIC DISCOVERY INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.28M$1.29-11.64%-$9.75M-0.18x51.82
AMIX
AUTONOMIX MEDICAL INC
NASDAQ
Medical Devices
$43.41M$2.31-7.60%N/AN/A-1.32
CDT
CONDUIT PHARMACEUTICALS INC
NASDAQ
Biotechnology
$214.84M$2.91-2.02%-$2.01M-0.00x-2.59
BOLD
BOUNDLESS BIO INC
NASDAQ
Biotechnology
$236.34M$10.629.82%N/AN/A-1.83
FBLG
FIBROBIOLOGICS INC
NASDAQ
Biotechnology
$359.91M$11.00-3.08%N/AN/A-3.95
ONMD
ONEMEDNET CORP
NASDAQ
Health Information Services
$11.21M$0.471.08%-$22.43M-0.48x-1.04
ONCO
ONCONETIX INC
NASDAQ
Biotechnology
$3.55M$0.161.92%-$44.48M-0.06x-1.18
PACS
PACS GROUP INC
NYSE
Medical Care Facilities
$4.22B$28.551.21%N/AN/A29.16
ICU
SEASTAR MEDICAL HOLDING CORP
NASDAQ
Biotechnology
$30.92M$0.416.22%-$32.88M-0.41x-2.73
NRXS
NEURAXIS INC
NYSEMKT
Biotechnology
$19.74M$2.97-2.30%-$14.15M-0.80x-1.30
GALT
GALECTIN THERAPEUTICS INC
NASDAQ
Biotechnology
$196.39M$3.16-2.17%-$41.25M-4.27x-1.33
OTLK
OUTLOOK THERAPEUTICS INC
NASDAQ
Biotechnology
$186.07M$7.952.19%-$156.86M-0.70x-1.44
MAIA
MAIA BIOTECHNOLOGY INC
NYSEMKT
Biotechnology
$74.46M$3.413.02%-$23.72M-2.16x-2.51
MDAI
SPECTRAL AI INC
NASDAQ
Medical Devices
$32.17M$1.845.14%-$19.77M-1.57x-8.64
ALUR
ALLURION TECHNOLOGIES INC
NYSE
Medical Devices
$81.03M$1.69-4.52%-$44.97M-0.46x-1.91
ERNA
ETERNA THERAPEUTICS INC
NASDAQ
Biotechnology
$11.25M$2.084.00%-$19.90M-0.49x-15.55
NLSP
NLS PHARMACEUTICS LTD
NASDAQ
Biotechnology
$6.31M$0.187.93%-$12.02M-0.55x-1.21
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
NASDAQ
Biotechnology
$42.99M$1.54-7.78%-$40.07M-0.97x-11.03
BCLI
BRAINSTORM CELL THERAPEUTICS INC
NASDAQ
Biotechnology
$39.74M$0.579.04%-$14.73M-1.77x-1.60
AEON
AEON BIOPHARMA INC
NYSEMKT
Biotechnology
$66.51M$1.7011.11%-$323.91M-0.19x-1.05
BGXX
BRIGHT GREEN CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$42.60M$0.22-2.61%-$10.84M-3.20x0.44
NKGN
NKGEN BIOTECH INC
NASDAQ
Biotechnology
$42.56M$1.7152.68%-$76.74M-0.37x-1.30
CLDI
CALIDI BIOTHERAPEUTICS INC
NYSEMKT
Biotechnology
$12.63M$0.258.77%-$27.77M-0.36x-1.51
PBM
PSYENCE BIOMEDICAL LTD
NASDAQ
Biotechnology
$11.72M$0.880.57%$1.52M-87.50x-1.79
OCEA
OCEAN BIOMEDICAL INC
NASDAQ
Biotechnology
$55.32M$1.62-7.95%-$97.33M-0.41x-1.01
TVGN
TEVOGEN BIO HOLDINGS INC
NASDAQ
Biotechnology
$128.40M$0.78-4.88%-$58.89M-0.32x-1.06
NIVF
NEWGENIVF GROUP LTD
NASDAQ
Medical Care Facilities
$10.93M$1.3216.81%-$690.85k-1.07x-1.01
NUVO
LAMF GLOBAL VENTURES CORP I
NASDAQ
Medical Devices
$23.41M$1.77-1.67%N/A-0.95x-0.58
INKT
MINK THERAPEUTICS INC
NASDAQ
Biotechnology
$35.07M$1.010.00%-$20.37M-1.71x-1.34

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
678+0.74%+2.09%+6.36%-20.75%8.16x6.06x+18.37%+3.70%-27.15%+77.15%Strong Buy
64-0.34%+2.22%+12.40%+8.46%39.05x4.47x-13.16%+6.46%+11.46%+5.34%Buy
18+0.48%+1.89%+7.64%+18.88%32.93x6.42x+33.66%+8.08%+14.20%+10.49%Buy
87+0.27%+0.58%+6.24%-3.67%-1.08x2.21x+12.46%+3.39%+6.12%+31.76%Strong Buy
12-1.10%+0.04%+1.12%+4.69%25.19x3.03x+15.18%+4.74%+11.78%+13.37%Buy
61-0.19%+1.63%-1.19%-22.50%10.68x3.32x+6.76%+2.25%+5.35%+27.15%Buy
51+0.19%+0.62%+4.65%+11.39%37.64x4.62x-92.27%+6.58%+13.67%+14.97%Buy
150-0.33%+1.75%+3.10%-14.72%30.55x3.98x+7.33%+5.24%+8.23%+20.25%Buy
10-0.52%+0.61%+0.95%+26.67%26.75x106.68x-12.18%+3.44%+19.61%+11.48%Buy
56-0.23%+1.99%+6.12%-6.85%59.90x3.63x+11.21%+7.72%+10.03%+18.87%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -41.26% over the past year, underperforming other healthcare stocks by -34 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 34.58% from Cross Country Healthcare's current stock price of $14.49.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best healthcare stock with a Zen Score of 64, which is 40 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -11.18% over the past year, underperforming other healthcare stocks by -4 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 31.01% from Incyte's current stock price of $57.19.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the third best healthcare stock with a Zen Score of 64, which is 40 points higher than the healthcare sector average of 24. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 17.21% over the past year, overperforming other healthcare stocks by 24 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 40.81% from Corcept Therapeutics's current stock price of $28.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)


Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.14%, which is 6 percentage points higher than the healthcare sector average of 2.07%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.95%, which is 6 percentage points higher than the healthcare sector average of 2.07%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.82%, which is 6 percentage points higher than the healthcare sector average of 2.07%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.04% in the last day, and up 1.67% over the last week. Scorpius Holdings was the among the top gainers in the healthcare sector, gaining 55.34% yesterday.

Scorpius shares are trading higher after the company announced expansion in San Antonio with a new storage and testing facility.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.54% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -26.17% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -41.26% in the past year. It has underperformed other stocks in the healthcare sector by -34 percentage points.

Are healthcare stocks a good buy now?

50.4% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.73% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.